- Advertisement -
The European Union on Thursday approved the highly contentious Alzheimer’s medication Kisunla under strict conditions, with the drug’s effectiveness hotly debated by the medical community.
…
The European Union on Thursday approved the highly contentious Alzheimer’s medication Kisunla under strict conditions, with the drug’s effectiveness hotly debated by the medical community.
…